|
-
|
History of Marburg outbreaks |
CDC |
2025 |
|
-
|
History of Ebola outbreaks |
CDC |
2025 |
|
PMID 26439085
|
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus |
Messaoudi |
2015 |
|
PMID 38040006
|
Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review |
Cuomo-Dannenburg |
2024 |
|
PMID 31980636
|
Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa |
Amman |
2020 |
|
PMID 36969842
|
Ebanga: the most recent FDA-approved drug for treating Ebola |
Taki |
2023 |
|
PMID 38489257
|
W., Mahmoud, O., Zakhour, J. & Kanj, S. S. Recent advances in the treatment of Ebola disease: a brief overview |
El Ayoubi |
2024 |
|
PMID 15043007
|
Virus entry: molecular mechanisms and biomedical applications |
Dimitrov |
2004 |
|
PMID 25866377
|
Viral membrane fusion. Virology 479–480, 498–507 (2015) |
Harrison |
2015 |
|
PMID 26771495
|
Ebola viral glycoprotein bound to its endosomal receptor Niemann–Pick C1 |
Wang |
2016 |
|
PMID 27238017
|
Structural insights into the Niemann–Pick C1 (NPC1)-mediated cholesterol transfer and Ebola infection |
Gong |
2016 |
|
PMID 27362232
|
Toremifene interacts with and destabilizes the Ebola virus glycoprotein |
Zhao |
2016 |
|
PMID 29324225
|
The Marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding |
King |
2018 |
|
PMID 20862315
|
F., Kolokoltsov, A. A., Albrecht, T. & Davey, R. A |
Saeed |
2010 |
|
PMID 15831716
|
J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection |
Chandran |
2005 |
|
PMID 21866103
|
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1 |
Carette |
2011 |
|
PMID 32040508
|
Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca 2+ , and receptor binding |
Das |
2020 |
|
PMID 22395071
|
Ebola virus entry requires the host-programmed recognition of an intracellular receptor |
Miller |
2012 |
|
PMID 25723165
|
Structural basis for Marburg virus neutralization by a cross-reactive human antibody |
Hashiguchi |
2015 |
|
PMID 27865111
|
Camelid and shark single domain antibodies: structural features and therapeutic potential |
Könning |
2017 |
|
PMID 24698358
|
Nanobody-based products as research and diagnostic tools |
De Meyer |
2014 |
|
PMID 35018939
|
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 14, 1054–1074 (2022) |
Du |
2022 |
|
-
|
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses |
Yang |
2024 |
|
PMID 39236072
|
Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants |
Ye |
2024 |
|
PMID 39715280
|
Discovery of Nanosota-EB1 and -EB2 as novel nanobody inhibitors against Ebola virus infection |
Bu |
2024 |
|
PMID 16357862
|
Virus membrane-fusion proteins: more than one way to make a hairpin |
Kielian |
2006 |
|
PMID 26917592
|
Structural and molecular basis for Ebola virus neutralization by protective human antibodies |
Misasi |
2016 |
|
PMID 25428871
|
Receptor recognition mechanisms of coronaviruses: a decade of structural studies |
Li |
2015 |
|
PMID 27578435
|
Structure, function, and evolution of coronavirus spike proteins |
Li |
2016 |
|
PMID 25723164
|
Mechanism of human antibody-mediated neutralization of Marburg virus |
Flyak |
2015 |
|
PMID 20084270
|
A., Marriott, H. M., Whyte, M. K. & Dockrell, D. H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages |
Daigneault |
2010 |
|
PMID 39894818
|
Cryo-EM structure of Sudan Ebolavirus glycoprotein complexed with its human endosomal receptor NPC1 |
Bu |
2025 |
|
PMID 32234486
|
Structure-based design of prefusion-stabilized filovirus glycoprotein trimers |
Rutten |
2020 |
|
PMID 39591462
|
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate |
Ye |
2024 |
|
-
|
Discovery of Nanosota-2,-3, and-4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19 |
Ye |
2023 |
|
PMID 36256797
In OmniVira
|
Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant. |
Zhang |
2022 |
|
PMID 39083418
In OmniVira
|
Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses. |
Zhang |
2024 |
|
PMID 35241675
|
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain |
Ye |
2022 |
|
-
|
Efficient strategies and troubleshooting for single particle cryoEM data collection using EPU. BMC Methods 2, 3 (2025) |
Bhandari |
2025 |
|
PMID 28165473
|
L., Fleet, D |
Punjani |
2017 |
|
PMID 26296328
|
Alignment of cryo-EM movies of individual particles by optimization of image translations |
Rubinstein |
2015 |
|
PMID 26278980
|
CTFFIND4: fast and accurate defocus estimation from electron micrographs |
Rohou |
2015 |
|
PMID 37982712
|
Integrating AlphaFold and deep learning for atomistic interpretation of cryo-EM maps. Brief |
Dai |
2023 |
|
PMID 15572765
|
Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004) |
Emsley |
2004 |
|
PMID 20124702
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010) |
Adams |
2010 |
|
PMID 28710774
|
UCSF ChimeraX: meeting modern challenges in visualization and analysis |
Goddard |
2018 |
|
-
|
PyMOL: an open-source molecular graphics tool. CCP4 Newsl |
DeLano |
2002 |
|
PMID 21919503
|
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery |
Laskowski |
2011 |